Background: Prostrate cancer is a leading health concern among men, with increasing global incidence and mortality especially in low and middle-income countries. Despite its impact, limited data exist on PSA screening trends and influencing factors in Southeast Nigeria, particularly Umuahia, highlighting the need for localized evidence to improve early detection and intervention. Aim: The main objective of this work is focused on studying of prostate cancer screening among male patients that attended Madonna Catholic Hospital in Umuahia, Abia State from 2020-2024. Method: A retrospective study was used to identify patients who attended the hospital between 2020-2024 and had a diagnosis of prostate cancer or underwent prostate related procedures. Stratified sampling was used to divide the study population into strata based on age groups and year of admission. Systematic sampling was used to select every patient from each stratum. Results: The findings reveal an upward trend in screening uptake, rising from 88 participants in 2020 to 202 in 2024, with a total of 594 men screened over five years. The majority were aged 50–69 years (63.8%), aligning with global prostate cancer risk profiles. Elevated prostate-specific antigen (PSA) levels (≥4 ng/mL) were observed in 54.2% of participants, indicating a high burden of potential late-stage disease. Conclusion: The study highlights the need for age and comorbidity sensitive prostate cancer in Nigeria emphasizing hypertension’s role and urging context-specific guidelines to improve early detection and health outcomes.
Uka-Kalu et al. (Wed,) studied this question.